Market revenue in 2023 | USD 117.3 million |
Market revenue in 2030 | USD 172.9 million |
Growth rate | 5.7% (CAGR from 2023 to 2030) |
Largest segment | Coronary guidewires |
Fastest growing segment | Neurovascular guidewires |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Coronary guidewires, Peripheral guidewires, Urology guidewires, Neurovascular guidewires |
Key market players worldwide | Boston Scientific Corp, Medtronic PLC, COOK, B. Braun, Terumo Corp, Abbott Laboratories, Stryker Corp, Teleflex Inc, BD |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to guidewires market will help companies and investors design strategic landscapes.
Coronary guidewires was the largest segment with a revenue share of 45.61% in 2023. Horizon Databook has segmented the Canada guidewires market based on coronary guidewires, peripheral guidewires, urology guidewires, neurovascular guidewires covering the revenue growth of each sub-segment from 2018 to 2030.
Prevalence of heart diseases in Canada is high; this imposes an annual financial burden of about USD 22 billion. According to the Institute for Health Metrics and Evaluation (IHME), in 2018, ischemic heart disease was the leading cause of death and disability in Canada.
Waiting period for healthcare services is also considerably long in the country, with patients waiting for almost 4 weeks (on an average) for simple diagnostics services such as CT scans, 11 weeks for an MRI scan, and about 4 weeks for an ultrasound. This is expected to boost the demand for minimally invasive surgeries. Companies are increasingly investing in R&D of quality products due to faster product approval from regulatory bodies.
This is expected to positively influence market growth, leading to product developments pertaining to guidewires. In June 2016, Opsens, Inc. received approval from Health Canada for its optical guidewire, OptoWire II, which is used in the diagnosis of coronary stenosis.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada guidewires market , including forecasts for subscribers. This country databook contains high-level insights into Canada guidewires market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account